Skip Navigation

Cardiovascular Research 1999 43(1):67-76; doi:10.1016/S0008-6363(99)00053-X
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bokník, P.
Right arrow Articles by Neumann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bokník, P.
Right arrow Articles by Neumann, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Regional expression of phospholamban in the human heart

Peter Bokníka,*, Claus Unkela, Uwe Kirchhefera, Ulrich Kleideitera, Oliver Klein-Wielea, Jörg Knappa, Bettina Lincka, Hartmut Lüssa, Frank Ulrich Müllera, Wilhelm Schmitza, Ute Vahlensiecka, Norbert Zimmermannb, Larry R. Jonesc and Joachim Neumanna

aInstitut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität, Domagkstraße 12, D-48129 Münster, Germany
bKlinik für Thorax- und Kardiovaskuläre Chirurgie, Heinrich Heine-Universität, Moorenstraße 5, D-40001 Düsseldorf, Germany
cKrannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA

* Corresponding author. Tel.: +49-251-835-5503; fax: +49-251-835-5501.

Background: Several independent lines of evidence indicate that phospholamban (PLB) expression correlates positively with depression of force of contraction and duration of contraction in isolated cardiac preparations of several animal species. Here, we studied whether PLB levels correlate with attenuation of contractility and enhancement of contractile time parameters in different parts of the human heart. Methods: Force of contraction was measured in isolated electrically driven atrial and ventricular preparations from human hearts. Ca2+-uptake by human atrial and ventricular homogenates was assayed at different ionized Ca2+-concentrations. Protein expression of PLB and the sarcoplasmic Ca2+-ATPase (SERCA) was measured in homogenates by quantitative immunoblotting using specific antibodies. PLB mRNA expression was quantified in human cardiac preparations by Northern blot analysis. Results: The duration of contraction in isolated preparations of human right ventricle (RV) was double that found in right atrial preparations (RA) (620±25 ms versus 308±15 ms). In RA, PLB expression was reduced by 44% at the protein level and by 34% at the mRNA level compared to RV. In contrast, the SERCA protein content was increased by 104% in RA compared to RV. Ca2+-uptake at low ionized Ca2+-concentration, where the inhibiting effect of PLB is maximal, amounted to 1.39±0.28 nmol Ca2+/mg protein in RA and to 0.62±0.09 nmol Ca2+/mg protein in RV (n=6 both). Conclusions: It is suggested that duration of contraction is shorter in human atrium versus ventricle due to the combined effect of decreased PLB levels (which inhibits SERCA function) and increased SERCA levels. The lower relative ratio of PLB to SERCA leads to less inhibition of SERCA and increased Ca2+-uptake which enhances relaxation and contraction in human atrium.

KEYWORDS Atrial function; Contractile function; Gene expression; SR (function); Ventricular function


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.